Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability Study of SPARC001 vs Hydrocodone-Acetaminophen in Healthy Volunteers
NCT02991261Phase 1Completed
- Sponsor
- Sun Pharma
- Start
- Feb 2017
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hydrocodone bitartrate + acetaminophen in pain (4 arms), sponsored by Sun Pharma. Primary endpoints: Area Under the Curve at 48 hours and Maximum Plasma Concentration at 48 hours. Started Feb 2017; status: completed.
02
Drugs
hydrocodone bitartrate + acetaminophen
03
Conditions
pain
Beyond the preview
Go deeper on NCT02991261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02991261.